Varian Medical Systems (VAR) Shares Sold by First Trust Advisors LP

First Trust Advisors LP decreased its holdings in shares of Varian Medical Systems (NYSE:VAR) by 95.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,920 shares of the medical equipment provider’s stock after selling 89,227 shares during the period. First Trust Advisors LP’s holdings in Varian Medical Systems were worth $436,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. WASHINGTON TRUST Co raised its stake in Varian Medical Systems by 100.0% during the 4th quarter. WASHINGTON TRUST Co now owns 970 shares of the medical equipment provider’s stock worth $108,000 after buying an additional 485 shares during the period. Public Employees Retirement Association of Colorado raised its stake in Varian Medical Systems by 3.4% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 17,742 shares of the medical equipment provider’s stock worth $1,972,000 after buying an additional 585 shares during the period. Caisse DE Depot ET Placement DU Quebec raised its stake in Varian Medical Systems by 4.2% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 14,735 shares of the medical equipment provider’s stock worth $1,481,000 after buying an additional 600 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Varian Medical Systems by 9.3% during the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 7,466 shares of the medical equipment provider’s stock worth $747,000 after buying an additional 637 shares during the period. Finally, Sterling Capital Management LLC raised its stake in Varian Medical Systems by 19.5% during the 3rd quarter. Sterling Capital Management LLC now owns 4,099 shares of the medical equipment provider’s stock worth $410,000 after buying an additional 670 shares during the period. Institutional investors own 99.21% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of Varian Medical Systems stock opened at $122.65 on Monday. The company has a market capitalization of $11,197.95, a PE ratio of 34.07, a P/E/G ratio of 3.56 and a beta of 0.85. Varian Medical Systems has a 52 week low of $87.49 and a 52 week high of $130.29.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, January 24th. The medical equipment provider reported $1.06 EPS for the quarter, topping the consensus estimate of $1.00 by $0.06. The firm had revenue of $678.50 million during the quarter, compared to the consensus estimate of $633.96 million. Varian Medical Systems had a return on equity of 27.13% and a net margin of 4.27%. The company’s quarterly revenue was up 12.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.09 earnings per share. equities research analysts predict that Varian Medical Systems will post 4.31 EPS for the current year.

A number of research analysts recently weighed in on the company. Royal Bank of Canada upped their price target on Varian Medical Systems to $115.00 and gave the stock a “sector perform” rating in a research note on Thursday, January 25th. Citigroup upped their price target on Varian Medical Systems from $128.00 to $132.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. Zacks Investment Research raised Varian Medical Systems from a “hold” rating to a “buy” rating and set a $142.00 price target on the stock in a research note on Tuesday, March 13th. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a research note on Sunday, January 28th. Finally, Goldman Sachs downgraded Varian Medical Systems from a “neutral” rating to a “sell” rating and set a $98.00 price target on the stock. in a research note on Thursday, January 25th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $111.80.

In other news, EVP Kolleen T. Kennedy sold 699 shares of the stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $126.47, for a total value of $88,402.53. Following the completion of the sale, the executive vice president now directly owns 27,361 shares of the company’s stock, valued at $3,460,345.67. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Timothy E. Guertin sold 10,000 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $111.46, for a total value of $1,114,600.00. Following the sale, the director now directly owns 2,161 shares of the company’s stock, valued at $240,865.06. The disclosure for this sale can be found here. Over the last three months, insiders sold 100,568 shares of company stock valued at $12,019,913. Company insiders own 0.78% of the company’s stock.

WARNING: This piece of content was first reported by WKRB News and is the sole property of of WKRB News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.wkrb13.com/2018/04/02/varian-medical-systems-var-shares-sold-by-first-trust-advisors-lp.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply